SUMMARY One hundred nineteen patients with coronary artery disease confirmed by coronary arteriograms were studied. Cine coronary arteriography confirmed progression of atherosclerosis in 106 (89%) patients (mean age 50.9 yr) and nonprogression in 13 (11%) patients (mean age 50.3 yr). Progression was defined as follows: any increase to 50% stenosis, 50% to 75% narrowing, 75% to 90%, 90% to 99%, 99% to total occlusion.
Discussion
There were no significant differences between the average age of the 106 patients who progressed (50.9, range 32-67 yr) and the 13 patients who did not show progression (average 50.3, range 36-63 yr). There was significant coronary artery disease in every patient studied. Patients who had less than 50% narrowing were specifically excluded. Almost all the patients had lesions greater than 50% narrowing. Only three of the 106 in the progression group and one of the 13 patients in the nonprogression group had no lesion greater than 50%. Conversely, 103 of 106 progressive patients and 12 of 13 nonprogressive patients had 75% or greater lesions. In most the lesion was 90% or greater; 84 of the 106 progressive patients and 12 of the nonprogressive patients had at least one 90% obstruction.
In order to address the question of minimal progression, we examined the data to identify those patients who progressed only from 90% to 99% or from 99% to total occlusion. Only three patients fell into this category. Such minor progression may, however, have had major clinical consequences.
The duration of the atherosclerotic disease could not be measured accurately in this retrospective study. Some charts lacked fundamental information on smoking, hypertension, and family history of vascular disease. Most of the original 121 patients with repetitive arteriograms who could not be included in this study were rejected because of inadequate lipid determinations. Most did not have a single triglyceride determination documented.
The interval between arteriograms averaged 20.9 months (range 2-67) in the patients who progressed and 21.3 months ERYSICHTHON SYNDROME/Nash et al.
(range 11-54) in the patients who did not progress. There were no significant differences between the groups in the average age of the patients, the average interval between arteriograms, or the prevalence of diabetes mellitus. There were significant differences in the prevalence of family history of cardiovascular disease, hypertension, cigarette smoking, and lipid levels.
Despite the many publications which have documented the relationship between hyperlipidemia and coronary artery disease,12 patients and some physicians remain unconvinced. Some authors would prefer to believe that cholesterol is not a risk factor for coronary artery disease. In a recent editorial Oliver stated that dietary cholesterol is not an important cause of coronary heart disease. ' Coronary artery disease is an enigma, a mosaic of risks and causes, but once we can identify the interaction, treatment can be more specific. Physicians responsible for patients with documented coronary artery disease should insist upon a return to ideal values. Our study and others suggest that we have reached a watershed in medicine.9 10, 17, 18 The evidence, although limited, suggests that we can halt the progress of coronary artery disease.
